Pfizer PE Ratio
PE ratio as of May 2025 (TTM) : 32.74 | Industry PE : 45.08
Last Updated Date: 14th May, 2025Pfizer PE ratio analysis
- PE Ratio of Pfizer has increased by 29.08% compared to the previous Financial Year.
- PE Ratio with value of 41.57 was highest in Year 2021 in the last 5 years.
- PE Ratio with value of 26.96 was lowest in Year 2023 in the last 5 years.
- Latest PE Ratio with value of 34.80 is higher than the Average PE of 34.40 in the last 5 years.
Historical P/E Ratio of Pfizer
Pfizer PE ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2024 | 34.80 | +29.08% |
| 2023 | 26.96 | -17.05% |
| 2022 | 32.50 | -21.82% |
| 2021 | 41.57 | +14.93% |
| 2020 | 36.17 | -- |
PE Ratio Comparison with Peers of Pfizer
| Peers & Returns | Market Capitalization | PE Ratio |
|---|---|---|
| Jubilant Pharmova | 14,446.00 Cr | 285.68 |
| Astrazeneca Pharma India | 20,927.50 Cr | 82.36 |
| Concord Biotech | 15,594.09 Cr | 52.25 |
| J B Chemicals & Pharmaceuticals | 24,547.18 Cr | 47.03 |
| Blue Jet Healthcare | 12,545.89 Cr | 40.51 |
| Eris Lifesciences | 20,339.23 Cr | 38.17 |
Disclaimer: The figures and information provided are for informational purposes only and may vary over time. The above data may be outdated and not reflect the latest updates. Always conduct thorough research and consult a financial advisor before making any investment decisions.
Quick Links for Pfizer
Pfizer Balance Sheet | Pfizer Quarterly Result | Pfizer Stock Split History | Pfizer AGM / EGM | Pfizer Rights | Pfizer Board Meeting | Pfizer EPS | Pfizer Bonus | Pfizer ROE Ratio | Pfizer Shareholding | Pfizer Bulk and Block Deals | Pfizer Insider Trading and SAST | Pfizer PE | Pfizer PB | Pfizer Income statement | Pfizer Cashflow
Other Price to Earning Pages
Data Source - Dion Global Solutions Limited